IP Library › Granted Patent US 8,138,150
Granted Patent B2
US 8,138,150 · App. 13/079,806 · Granted Mar 20, 2012

Method for removing endotoxin from proteins

Assignee: Glanbia Nutritionals, Ireland (Ltd.)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,138,150
App. No.
13/079,806
Granted
Mar 20, 2012
Kind
B2
Abstract

Disclosed is a method for removing endotoxin from proteins. Also disclosed are products made by using the method. The method may be used, for example, to produce endotoxin-free lactoferrin. Bovine milk-derived lactoferrin may be produced in commercial quantities by the method, and endotoxin-free bovine lactoferrin may be used for a variety of therapeutic uses, including improving wound healing.

Claims (14)

1. A method for treating a biofilm-associated disease condition in a human or animal, the method comprising administering to the human or animal a therapeutically effective amount of an endotoxin-free bovine lactoferrin product made by removing bound endotoxin from lactoferrin by a method comprising the steps of

a) binding the lactoferrin to a cation exchange resin;

b) eluting the endotoxin using a low-ionic strength solution in the absence of added surfactant; and

c) eluting the lactoferrin with a high ionic strength solution.

2. The method of claim 1 wherein the low-ionic strength solution is a 0.01 to 0.5 molar salt solution.

3. The method of claim 1 wherein the low-ionic strength solution is a 0.25 to 0.35 molar salt solution.

4. The method of claim 1 wherein the high ionic strength solution is a high salt solution.

5. A method for improving healing in an acute or chronic wound, the method comprising administering to the human or animal a therapeutically effective amount of an endotoxin-free bovine lactoferrin product made by removing bound endotoxin from lactoferrin by a method comprising the steps of

a) binding the lactoferrin to a cation exchange resin;

b) eluting the endotoxin using a low-ionic strength solution in the absence of added surfactant; and

c) eluting the lactoferrin with a high ionic strength solution.

6. The method of claim 5 wherein the low-ionic strength solution is a 0.01 to 0.5 molar salt solution.

7. The method of claim 5 wherein the low-ionic strength solution is a 0.25 to 0.35 molar salt solution.

8. The method of claim 5 wherein the high ionic strength solution is a high salt solution.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2014
From: WROBEL, STANLEY; THOMSON, KEVIN; VINCENT, ANITA LIND
To: GLANBIA NUTRITIONALS (IRELAND) PLC
Reel/Frame 032140/0425 →
Continuity (3)
Continuation 12171264 · Jul 10, 2008
Provisional Application 60948839 · Jul 10, 2007
Related Publication 20120028882A1 · Feb 2, 2012